Unni Mukundan's action-packed film 'Marco', previously a box office hit, is set for its OTT release on SonyLiv from February 14. Directed by Haneef Adeni, the movie is called India's most-violent ...

Ah, the scorpion lollipop, a symbol of the Sonoran Desert. I like them, if only for the campiness of the dark, goth-looking scorpion encased unhappily in a gentle green, pink or blue. That said, ...

Malayalam OTT releases this week: A number of celebrated Malayalam movies will be available to watch this weekend. While the OTT release date for Sookshmadarshini is still under wraps, All We ...

Pushpa 2 The Rule Reloaded OTT release: It has officially been announced that Sukumar's sequel to Pushpa: The Rise will stream digitally soon. Pushpa 2 The Rule Reloaded OTT release: Sukumar’s ...

Pani OTT release: Pani marks Malayalam star Joju George's directorial debut. The movie hit the big screens on October 24 last year, following commercial success at box office, the revenge thriller ...

Investing.com -- Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including ...

Rifle Club OTT release: Aashiq Abu's ensemble film released in theatres in December and has now hit OTT on Netflix. Know all about it. Rifle Club OTT release: After a theatrical run of less than a ...

We look forward to leveraging the great work of the Scorpion team to date, along with Lilly's deep expertise in breast cancer, to further advance STX-478 with speed and focus." Under the terms of ...

Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan Healthcare Conference with a deal to buy Scorpion Therapeutics ...

It is exciting week for Malayalam cinema buffs. Four new movies are coming on popular OTT platforms this week. These movies include thriller and inspiring storylines. They are available on Netflix ...

Eli Lilly has agreed to acquire Scorpion Therapeutics’ breast cancer treatment program for up to $2.5 billion in cash. The drugmaker said Monday it is acquiring Scorpion and its STX-478 program ...

SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.